U.S. market Closed. Opens in 2 hours 57 minutes

EBAC | European Biotech Acquisition Corp. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-31
RevenueN/AN/A
Cost of RevenueN/AN/A
Gross ProfitN/AN/A
Operating Expenses2.82M1.10M
Selling, General & Admin2.79M1.10M
Research & DevelopmentN/AN/A
Other Operating Expenses32.94KN/A
Operating Income-2.82M-1.10M
Other Expenses / Income3.16M2.58M
Before Tax Income342.89K1.48M
Income Tax Expenses-3.16MN/A
Net Income3.50M1.48M
Interest Expenses-3.16MN/A
Basic Shares Outstanding12.75M13.66M
Diluted Shares Outstanding12.75M13.66M
EBITDA-5.98M-3.68M
EBITDA Margin0.00%0.00%
EBIT-2.82M1.48M
EBIT Margin0.00%0.00%
Financial Year End2022-12-312021-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙